Stocktoria
iBio, Inc. IBIO
iBio, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $400,000 | $225,000 | $0 | $1.9M | $2.4M | $1.6M | $2.0M | $444,000 | $394,000 | $948,000 |
| Gross profit | — | — | — | — | $909,000 | $935,000 | — | — | — | — |
| R&D expense | $8.3M | $5.2M | $10.3M | $9.8M | $10.0M | $3.6M | $5.5M | $4.0M | $4.1M | $3.2M |
| Operating income | -$18.6M | -$16.6M | -$29.3M | -$29.7M | -$31.1M | -$14.0M | -$15.8M | -$14.2M | -$14.3M | -$9.9M |
| Interest expense | — | — | $83,000 | $1.4M | $2.5M | $2.5M | $1.9M | $1.9M | $1.9M | $807,000 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$18.4M | -$24.9M | -$65.0M | -$50.3M | -$23.2M | -$16.4M | -$17.6M | -$16.1M | -$14.5M | -$9.8M |
| EPS (diluted) | $-1.75 | $-6.50 | $-106.19 | $-5.78 | $-3.00 | — | — | — | — | — |
| Operating cash flow | -$15.3M | -$18.6M | -$30.4M | -$37.5M | -$30.1M | -$13.3M | -$14.0M | -$13.5M | -$13.2M | -$8.1M |
| Free cash flow | -$15.3M | -$18.8M | -$36.2M | -$44.8M | -$35.0M | -$14.4M | -$14.9M | -$14.4M | -$14.5M | -$8.1M |
| Cash & equivalents | $8.6M | $14.2M | $4.3M | $22.7M | $77.4M | $55.1M | $4.4M | $4.4M | $15.9M | $15.9M |
| Inventory | — | $0 | $0 | $3.9M | $27,000 | — | — | — | — | — |
| Total assets | $23.2M | $28.7M | $41.2M | $99.4M | $147.0M | $94.2M | $30.6M | $43.1M | $36.0M | $51.6M |
| Total liabilities | $8.3M | $7.4M | $25.8M | $35.9M | $38.4M | $37.6M | $28.1M | $26.9M | $27.1M | $27.6M |
| Shareholders' equity | $14.9M | $21.3M | $15.4M | $63.5M | $108.6M | $56.6M | $2.5M | $16.2M | $8.9M | $24.0M |
Growth · year-over-year · Revenue CAGR -9.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +77.8% | — | -100.0% | -20.5% | +44.7% | -18.8% | +354.5% | +12.7% | -58.4% | -48.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.